Neoplasms of the Respiratory System

Neoplasms of the Respiratory System — Internal Medicine

How it begins

Estudio exhaustivo de la oncología torácica — biología molecular, clasificación histológica, estadificación TNM, correlaciones clínicas y estrategias terapéuticas actuales.

What it covers

1. Introduction and Epidemiology
2. · 1.1 Global and National Epidemiology
3. · 1.2 Risk Factors
4. Bronchogenic Carcinoma
5. · 2.1 Histological Classification (WHO 2021)
6. · 2.2 Molecular Pathogenesis and Signaling Pathways
7. · 2.3 Pulmonary Adenocarcinoma
8. · 2.4 Epidermoid Carcinoma (Squamous Cell)
9. · 2.5 Large Cell Carcinoma
10. · 2.6 Small Cell Carcinoma (CBCP)
11. Diagnosis of Bronchogenic Carcinoma
12. · 3.1 Clinical Presentation
13. · 3.2 Diagnostic Imaging
14. · 3.3 Bronchoscopy and Tissue Collection Techniques
15. · 3.4 Molecular Biomarkers — Mandatory Profile in 2025
16. TNM Staging of Lung Cancer
17. · 4.1 Description of the TNM System (9th Edition, 2024)
18. · 4.2 Stadium and Survival Groups
19. Advanced Clinical Manifestations
20. · 5.1 Paraneoplastic Syndromes
21. · 5.2 Pancoast Syndrome (Superior Sulcus Tumor)
22. · 5.3 Superior Vena Cava Syndrome (SVCS)
23. Treatment of CBNCP
24. · 6.1 Thoracic Surgery — Curative Treatment
25. · 6.2 Radiotherapy at the CBNCP
26. · 6.3 Cytotoxic Chemotherapy
27. · 6.4 Targeted Therapy
28. · 6.5 Immunotherapy — Checkpoint Inhibitors
29. Treatment of Small Cell Carcinoma (CBCP)
30. · 7.1 Limited Disease (LE)
31. · 7.2 Extensive Disease (EE)
32. · 7.3 Therapeutic Developments in CBCP — Emerging Perspectives
33. Pleural Malignant Mesothelioma
34. · 8.1 Etiology and Pathogenesis
35. · 8.2 Histological Classification
36. · 8.3 Diagnosis
37. · 8.4 Treatment
38. Pulmonary Carcinoid Tumors
39. · 9.1 Clinical Presentation
40. · 9.2 Functional Imaging Diagnosis
41. · 9.3 Treatment
42. Pulmonary Metastases
43. · 10.1 Most Common Primary Tumors
44. · 10.2 Radiological Pattern of Metastases
45. · 10.3 Pulmonary Metastasectomy
46. Screening, Prognosis and Future Prospects
47. · 11.1 Screening with Low Dose Computed Tomography (LDCT)
48. · 11.2 Prognostic Factors
49. · 11.3 Future Perspectives and Advanced Precision Oncology